FRANKFURT (REUTERS) -German healthcare and materials group Merck KGaA has struck a deal, it said on Monday, to acquire U.S.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), a biotechnology company that pioneered the use of human hyaluronidase ...

Merck & Co (NYSE: MRK) reported stronger-than-expected earnings for the first quarter while trimming its profit outlook for ...

Application (24A720) granted by Justice Alito extending the time to file until March 19, 2025. Motion to extend the time to ...